Citations 1
Etrolizumab induction therapy improves patient-reported outcomes, endoscopic activity and histologic severity in patients with moderate-severe Ulcerative colitis after failure of anti-TNF therapy: results from the HICKORY open label induction trial
Rubin, DT, Feagan, Brian G. , Oh, YS, Tyrrell, Helen E.J., Pai, RK, Boruvka, Audrey, Scherl, Alexis , Williams, S., Tole, Swati, Thommes, James, Hasselblatt, Peter , Peyrin‐Biroulet, Laurent , Rubin, DT, Williams, S
Zeitschrift für Gastroenterologie | September 22, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available
